{"transactions":[{"id":866336,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:34:10.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":14411,"price":3.84,"value":55338.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":1023643,"source":{"system":"sec-edgar","filing":"0002064832-26-000086","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000086/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":866335,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-03T16:34:10.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":43212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing."}],"balance_after":1038054,"source":{"system":"sec-edgar","filing":"0002064832-26-000086","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000086/form4a.xml","form_type":"4/A","original_submission_date":"2026-02-20"}},{"id":890542,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T17:29:07.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":115812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2026."}],"balance_after":115812,"derivative":{"exercise_price":3.84,"expiration_date":"2036-02-18","underlying":"Class A Common Stock","underlying_shares":115812},"source":{"system":"sec-edgar","filing":"0002064832-26-000062","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000062/form4.xml","form_type":"4"}},{"id":890541,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:29:07.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":14267,"price":3.84,"value":54785.28,"ownership":{"direct":true},"balance_after":1023355,"source":{"system":"sec-edgar","filing":"0002064832-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000062/form4.xml","form_type":"4"}},{"id":890540,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:29:07.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":42780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones."}],"balance_after":1037622,"source":{"system":"sec-edgar","filing":"0002064832-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000062/form4.xml","form_type":"4"}},{"id":890539,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T17:29:07.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":203125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026."}],"balance_after":994842,"source":{"system":"sec-edgar","filing":"0002064832-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000062/form4.xml","form_type":"4"}},{"id":896533,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:02.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":13510,"price":3.73,"value":50392.3,"ownership":{"direct":true},"balance_after":791717,"source":{"system":"sec-edgar","filing":"0002064832-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000028/form4.xml","form_type":"4"}},{"id":896532,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:02.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":12761,"price":3.73,"value":47598.53,"ownership":{"direct":true},"balance_after":805227,"source":{"system":"sec-edgar","filing":"0002064832-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000028/form4.xml","form_type":"4"}},{"id":896531,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:02.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":24428,"price":3.73,"value":91116.44,"ownership":{"direct":true},"balance_after":817988,"source":{"system":"sec-edgar","filing":"0002064832-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000028/form4.xml","form_type":"4"}},{"id":896530,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T16:37:02.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4043,"price":3.73,"value":15080.39,"ownership":{"direct":true},"balance_after":842416,"source":{"system":"sec-edgar","filing":"0002064832-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000206483226000028/form4.xml","form_type":"4"}},{"id":1119443,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-06T17:44:18.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":9022,"price":2.987,"value":26948.714,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.945 to $3.00, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":846459,"source":{"system":"sec-edgar","filing":"0001062993-25-011161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325011161/form4.xml","form_type":"4"}},{"id":1119442,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-06T17:44:18.000Z","date":"2025-06-05","kind":"purchase","planned":false,"acquired":true,"shares":142379,"price":2.9051,"value":413625.2329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.815 to $2.98, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":837437,"source":{"system":"sec-edgar","filing":"0001062993-25-011161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325011161/form4.xml","form_type":"4"}},{"id":1119441,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-06T17:44:18.000Z","date":"2025-06-04","kind":"purchase","planned":false,"acquired":true,"shares":100863,"price":2.8228,"value":284716.0764,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.74 to $2.875, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":695058,"source":{"system":"sec-edgar","filing":"0001062993-25-011161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325011161/form4.xml","form_type":"4"}},{"id":1252654,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-21T17:51:04.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":167625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2025."}],"balance_after":167625,"derivative":{"exercise_price":3.53,"expiration_date":"2035-02-19","underlying":"Class A Common Stock","underlying_shares":167625},"source":{"system":"sec-edgar","filing":"0001062993-25-003226","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325003226/form4.xml","form_type":"4"}},{"id":1252653,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-21T17:51:04.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":162047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2025."}],"balance_after":594195,"source":{"system":"sec-edgar","filing":"0001062993-25-003226","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325003226/form4.xml","form_type":"4"}},{"id":1259584,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-19T19:18:08.000Z","date":"2025-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":646,"price":3.7,"value":2390.2,"ownership":{"direct":true},"balance_after":432148,"source":{"system":"sec-edgar","filing":"0001062993-25-002932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325002932/form4.xml","form_type":"4"}},{"id":1259583,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-19T19:18:08.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3070,"price":3.7,"value":11359.0,"ownership":{"direct":true},"balance_after":432794,"source":{"system":"sec-edgar","filing":"0001062993-25-002932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325002932/form4.xml","form_type":"4"}},{"id":1259582,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-19T19:18:08.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":22178,"price":3.7,"value":82058.6,"ownership":{"direct":true},"balance_after":435864,"source":{"system":"sec-edgar","filing":"0001062993-25-002932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325002932/form4.xml","form_type":"4"}},{"id":1259581,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-19T19:18:08.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11230,"price":3.7,"value":41551.0,"ownership":{"direct":true},"balance_after":458042,"source":{"system":"sec-edgar","filing":"0001062993-25-002932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299325002932/form4.xml","form_type":"4"}},{"id":1549183,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2024-04-03T16:23:24.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1974,"price":2.8,"value":5527.2,"ownership":{"direct":true},"balance_after":469272,"source":{"system":"sec-edgar","filing":"0001062993-24-007935","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299324007935/form4.xml","form_type":"4"}},{"id":1622297,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-23T17:23:36.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":276737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2024."}],"balance_after":276737,"derivative":{"exercise_price":3.43,"expiration_date":"2034-02-21","underlying":"Class A Common Stock","underlying_shares":276737},"source":{"system":"sec-edgar","filing":"0001062993-24-004312","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299324004312/form4.xml","form_type":"4"}},{"id":1622296,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-23T17:23:36.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":153061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2024."}],"balance_after":471246,"source":{"system":"sec-edgar","filing":"0001062993-24-004312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299324004312/form4.xml","form_type":"4"}},{"id":1633371,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-20T20:18:35.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":646,"price":3.48,"value":2248.08,"ownership":{"direct":true},"balance_after":318185,"source":{"system":"sec-edgar","filing":"0001062993-24-003763","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299324003763/form4.xml","form_type":"4"}},{"id":1633370,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-20T20:18:35.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3643,"price":3.68,"value":13406.24,"ownership":{"direct":true},"balance_after":318831,"source":{"system":"sec-edgar","filing":"0001062993-24-003763","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299324003763/form4.xml","form_type":"4"}},{"id":1633369,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-20T20:18:35.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":21516,"price":3.68,"value":79178.88,"ownership":{"direct":true},"balance_after":322474,"source":{"system":"sec-edgar","filing":"0001062993-24-003763","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299324003763/form4.xml","form_type":"4"}},{"id":1927637,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Admin. and Legal Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-04T16:19:45.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2339,"price":2.13,"value":4982.07,"ownership":{"direct":true},"balance_after":343990,"source":{"system":"sec-edgar","filing":"0001062993-23-008506","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299323008506/form4.xml","form_type":"4"}},{"id":1992905,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-24T17:50:46.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":331076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2023."}],"balance_after":331076,"derivative":{"exercise_price":2.51,"expiration_date":"2033-02-22","underlying":"Class A Common Stock","underlying_shares":331076},"source":{"system":"sec-edgar","filing":"0001062993-23-004891","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299323004891/form4.xml","form_type":"4"}},{"id":1992904,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2023-02-24T17:50:46.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":278884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2023."}],"balance_after":346329,"source":{"system":"sec-edgar","filing":"0001062993-23-004891","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299323004891/form4.xml","form_type":"4"}},{"id":2007290,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2023-02-17T16:25:26.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":765,"price":2.75,"value":2103.75,"ownership":{"direct":true},"balance_after":67445,"source":{"system":"sec-edgar","filing":"0001062993-23-004059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299323004059/form4.xml","form_type":"4"}},{"id":2007289,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2023-02-17T16:25:26.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":3635,"price":2.92,"value":10614.2,"ownership":{"direct":true},"balance_after":68210,"source":{"system":"sec-edgar","filing":"0001062993-23-004059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299323004059/form4.xml","form_type":"4"}},{"id":2304044,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2022-04-05T18:19:15.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":2984,"price":7.89,"value":23543.76,"ownership":{"direct":true},"balance_after":71845,"source":{"system":"sec-edgar","filing":"0001062993-22-009811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299322009811/form4.xml","form_type":"4"}},{"id":2388171,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T18:53:29.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":99236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 15, 2022."}],"balance_after":99236,"derivative":{"exercise_price":8.03,"expiration_date":"2032-02-15","underlying":"Class A Common Stock","underlying_shares":99236},"source":{"system":"sec-edgar","filing":"0001062993-22-004798","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299322004798/form4.xml","form_type":"4"}},{"id":2388170,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2022-02-17T18:53:29.000Z","date":"2022-02-16","kind":"tax_withholding","acquired":false,"shares":765,"price":7.78,"value":5951.7,"ownership":{"direct":true},"balance_after":74829,"source":{"system":"sec-edgar","filing":"0001062993-22-004798","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299322004798/form4.xml","form_type":"4"}},{"id":2388169,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2022-02-17T18:53:29.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":41843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022."}],"balance_after":75594,"source":{"system":"sec-edgar","filing":"0001062993-22-004798","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000106299322004798/form4.xml","form_type":"4"}},{"id":2757474,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2021-04-05T20:46:49.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":1975,"price":19.83,"value":39164.25,"ownership":{"direct":true},"balance_after":33751,"source":{"system":"sec-edgar","filing":"0000899243-21-014959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000089924321014959/doc4.xml","form_type":"4"}},{"id":2849727,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T20:43:17.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":67444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning February 16, 2021."}],"balance_after":67444,"derivative":{"exercise_price":13.68,"expiration_date":"2031-02-16","underlying":"Class A Common Stock","underlying_shares":67444},"source":{"system":"sec-edgar","filing":"0001661181-21-000029","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000166118121000029/edgar.xml","form_type":"4"}},{"id":2849726,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2021-02-18T20:43:17.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":8808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 16, 2021."}],"balance_after":35726,"source":{"system":"sec-edgar","filing":"0001661181-21-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000166118121000029/edgar.xml","form_type":"4"}},{"id":3170094,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-24T07:56:10.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":177310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal annual installments over four years beginning April 1, 2020."}],"balance_after":177310,"derivative":{"exercise_price":4.04,"expiration_date":"2030-04-22","underlying":"Class A Common Stock","underlying_shares":177310},"source":{"system":"sec-edgar","filing":"0001661181-20-000016","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000166118120000016/edgar.xml","form_type":"4"}},{"id":3170093,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Class A Common Stock","published_at":"2020-04-24T07:56:10.000Z","date":"2020-04-22","kind":"grant","acquired":true,"shares":26918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning April 1, 2020."}],"balance_after":26918,"source":{"system":"sec-edgar","filing":"0001661181-20-000016","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000166118120000016/edgar.xml","form_type":"4"}},{"id":3733919,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":63240,"kind":"person","name":"Freedman Lori","position":1,"cik":"0001410291","reported_name":"Freedman Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-12T20:05:09.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":40600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in connection with the Issuer's business combination (the \"Merger\") with Organogenesis Inc. (\"Organogenesis\") in accordance with the terms of the Agreement and Plan of Merger dated as of August 17, 2018 among the Issuer, which was then referred to as Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis, in exchange for an option to acquire 20,000 shares of common stock of Organogenesis for $10.95 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vested or shall vest 20% annually beginning on January 30, 2018."}],"balance_after":40600,"derivative":{"exercise_price":5.4,"expiration_date":"2028-02-21","underlying":"Common  Stock","underlying_shares":40600},"source":{"system":"sec-edgar","filing":"0001661181-18-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410291/000166118118000039/edgar.xml","form_type":"4"}}]}